The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

Windlas Biotech's new GMP-certified injectable facility expands manufacturing capabilities for global pharmaceutical markets.

Araris Biotech AG, a Swiss oncology biotech firm, has partnered with Chugai Pharmaceutical to develop advanced antibody-drug conjugates (ADCs) using Araris’ AraLinQ platform, the company said.

PISCATAWAY, N.J., Jan. 7, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply ...

GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

Orbis Medicines has raised €90m ($94m) in Series A funding to advance the development of its next-generation orally dosable macrocycle drugs.

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...

It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

SpringWorks has shown strong revenue growth with OGSIVEO, achieving a 23% increase from Q2 of 2024 to Q3 of 2024. See why I ...

LBT-3627 is under clinical development by Longevity Biotech and currently in Phase I for Parkinson’s Disease. According to GlobalData, Phase I drugs for Parkinson’s Disease ha ...